{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"57"}],"units":"Participants"}],"description":"Number of participants with results of pathological review that indicated a complete response. Pathological complete response should be evaluated at the time of surgery (Extrapleural Pneumonectomy \\[EPP\\]).\n\nResected tissue or pleural fluid should be sent for pathological and histological evaluation.","groups":[{"description":"pemetrexed: 500 mg/m2, intravenous, every 21 days x 4 cycles cisplatin: 75 mg/m2, intravenous, every 21 days x 4 cycles chemotherapy, surgery then chest radiation x 54 gray (Gy)","id":"OG000","title":"Pemetrexed"}],"paramType":"NUMBER","populationDescription":"All participants who had undergone surgery.","reportingStatus":"POSTED","timeFrame":"Surgery (at least 3 weeks post last dose of chemotherapy, up to a maximum interval of 8 weeks)","title":"Pathological Complete Response","type":"PRIMARY","unitOfMeasure":"participants"}